<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00533663</url>
  </required_header>
  <id_info>
    <org_study_id>BRSADJ0007</org_study_id>
    <secondary_id>7696</secondary_id>
    <secondary_id>BRSADJ0007</secondary_id>
    <nct_id>NCT00533663</nct_id>
  </id_info>
  <brief_title>Healing Touch During Chemotherapy Infusions for Women With Breast Cancer</brief_title>
  <official_title>Healing Touch During Chemotherapy Infusions for Women With Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <brief_summary>
    <textblock>
      To study the effectiveness of Healing Touch provided during chemotherapy infusions on the
      experience of women undergoing treatment for breast cancer. Healing Touch (HT) is a gentle,
      non-invasive form of energy-balancing work that promotes relaxation and can help manage the
      side effects of chemotherapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>FACT-B summary score</measure>
    <time_frame>Baseline, 6 wks, 14 wks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Domain scores for FACT-B; BSI-18; FACIT-Fatigue; nausea measured on a Likert scale</measure>
    <time_frame>Baseline, 6 wks, 14 wks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Early Stage Breast Cancer (Stage 1-3)</condition>
  <arm_group>
    <arm_group_label>Healing Touch (HT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A a gentle, non-invasive form of energy-balancing work that promotes relaxation and can help manage the side effects of chemotherapy. It occurs every other week (during their infusion).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Guided relaxation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Guided relaxation every other week (during their infusion).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard care</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Healing Touch</intervention_name>
    <description>every other week (during their infusion)</description>
    <arm_group_label>Healing Touch (HT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard care</intervention_name>
    <arm_group_label>standard care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>guided relaxation</intervention_name>
    <arm_group_label>Guided relaxation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:- Stage I or II breast cancer

          -  Post-op

          -  On treatment protocol of eight weeks of AC given every other week followed by 8 weeks
             of paclitaxel given every other week

          -  ECOG Performance Status: 0-2

          -  Speak and read English

        Exclusion Criteria:- Previous chemotherapy exposure

        - Concomitant energy work interventions (HT, Reiki, QiGong, acupuncture).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Ellie Guardino MD/PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kathy Turner RN, NP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 20, 2007</study_first_submitted>
  <study_first_submitted_qc>September 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2007</study_first_posted>
  <last_update_submitted>June 3, 2013</last_update_submitted>
  <last_update_submitted_qc>June 3, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Kathy Turner</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

